|
|
Article: Adaltis Announces 2007 Second Quarter Financial Results - Revenue up 22% with strong growth in China
- Article from:
- CCNMatthews Newswire
- Article date:
- August 8, 2007
CopyrightCopyright 2007 CCNMatthews Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
MONTREAL, QUEBEC--(CCNMatthews - Aug. 8, 2007) - Adaltis Inc.
(TSX:ADS), an international in vitro diagnostic (IVD) company, today
reported its second quarter 2007 financial results.
Financial Highlights:
- Revenue for the three months ended June 30, 2007 was $18.1
million compared to $14.8 million in 2006, an increase of $3.3
million or 22.3%. This increase is driven by $1.4 million of
increased sales in our higher margin products (including
Eclectica(TM) and other infectious disease product lines)
particularly in China and other emerging countries, $1.1 million of
growth in sales of lower margin products in Asia, and the positive
impact of foreign exchange fluctuations of $0.8 million.
- ...